Trials / Completed
CompletedNCT00649246
Prospective Assessment in Newborns for Diabetes Autoimmunity
1. Prospective Studies in Infants of the Immunopathogenesis of Type 1 Diabetes 2. Consortium for Identification of Environmental Triggers of Type 1 Diabetes: MCG/UF Clinical Center 3. Identification of Serum Protein Markers for Type 1 Diabetes Using Mass-Spectrometry Techniques 4. Validation of Microarray-Based Biomarkers for Type 1 Diabetes 5. Development of Microarray-Based Biomarkers for Type 1 Diabetes 6. Proteomic Changes/Progression of Human Type 1 Diabetes 7. Identification and Validation of Serum Biomarkers for T1D
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 25,055 (actual)
- Sponsor
- Augusta University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
This is an observational study designed to help researchers understand the genetics and pathogenesis of type 1 diabetes, and to identify biomarkers for disease and disease complication prediction.
Detailed description
This study is designed to identify people who are at risk for developing type 1 diabetes, based on their genetics, family history and autoimmunity status, and to understand the role genetics plays in the development of the complications associated with type 1 diabetes in patients already affected by type 1 diabetes.
Conditions
Timeline
- Start date
- 1997-07-01
- Primary completion
- 2010-08-01
- Completion
- 2010-08-01
- First posted
- 2008-04-01
- Last updated
- 2018-03-27
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00649246. Inclusion in this directory is not an endorsement.